Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...
Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...
A three-decade-old competition that has spawned three Nobel laureates is becoming victim to the chaos at the National Institutes of Health. The Community Wide Experiment on the Critical Assessment of ...
Isomorphic Labs, the UK-based biotech spinoff of Google DeepMind, is set to begin human trials of drugs designed by its Nobel ...
Demis Hassabis has been pondering what humans are supposed to do in the face of machine superintelligence for his entire life ...
Slime mould Dictyostelium discoideum protein complex Q55DI5 (AF-0000000066503175), annotated as a transcription elongation factor. The single chain looked disordered, but modelling the homodimer ...
Plus: Donald Trump is ordering US scientific agencies to deploy AI This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
AI has a lot of uses. From writing code to automation via robots. But that is just a part of the picture. AI can even help cure cancer. According to Australian techie Paul Conyngham, ChatGPT and ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results